Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patientsandrsquo; blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.Based on the data in Figures 1 and 2, the researchers should make which of the following conclusions about the overall change in mean blood plasma concentration and mean symptom score over time following dosage?a)Both mean blood plasma concentration and mean symptom score increase then decrease.b)Both mean blood plasma concentration and mean symptom score decrease then increase.c)Mean blood plasma concentration increases then decreases, and mean symptom score decreases then increases.d)Mean blood plasma concentration decreases then increases, and mean symptom score increases then decreases.Correct answer is option 'C'. Can you explain this answer?

Explore Courses UPSC Exam UPSC Test Series Free Notes EduRev Infinity

Open App

ACT Exam > ACT Questions > Directions:Read the passages and choose the b...

Directions: Read the passages and choose the best answer to each question.

Passage
Researchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.
Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).

In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.
After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.
In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.

Q. Based on the data in Figures 1 and 2, the researchers should make which of the following conclusions about the overall change in mean blood plasma concentration and mean symptom score over time following dosage?

a)
Both mean blood plasma concentration and mean symptom score increase then decrease.
b)
Both mean blood plasma concentration and mean symptom score decrease then increase.
c)
Mean blood plasma concentration increases then decreases, and mean symptom score decreases then increases.
d)
Mean blood plasma concentration decreases then increases, and mean symptom score increases then decreases.

Correct answer is option 'C'. Can you explain this answer?

Join for Free

Join for Free

Most Upvoted Answer

Directions:Read the passages and choose the best answer to each questi...

This question can be answered by observing the trends in the Figures or simply thinking critically about how medication generally works. According to Figure 2, it takes a bit of time for the medication to start working, the symptoms decline for a period of time, then, presumably once the medication starts to wear off, the symptoms return. Figure 1 shows that symptom relief is inversely proportional to concentration of the medication in the body.

Answered by Orion Classes · View profile

View all answers Start learning for free

Explore Courses for ACT exam

Similar ACT Doubts

Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.According to Figure 1, mean blood plasma concentration of Ingredient A administered in immediate-release form increases most during which of the following time periods?

View answer

Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.The symptom score of a clinical trial subject given the extended-release form of the prescription drug remained unchanged for 8 hours. Based on Figure 2, the 8-hour period most likely began

View answer

Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extendedrelease capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.Which of the following conclusions about adverse side effects caused by the prescription drug is consistent with the results shown in Table 1?

View answer

Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.According to Figure 1, 16 hours after taking the extended-release form of the prescription drug, the difference in mean blood plasma concentration between Ingredient A and Ingredient B is closest to

View answer

Directions:Read the passage and choose the best answer to each question.PassageA scientist tested the ability of 5 newly engineered drugs to kill penicillin-resistant bacteria.Experiment 1Equal numbers of penicillin-resistant bacteria were put into ﬂasks containing 10.0 milliliters of a nutrient medium.The ﬂasks were incubated for 1 hour at 37 C with different concentrations of the 5 drugs shown in Table 1. A control consisted of bacteria incubated in the medium without any drugs. The bacteria were washed to remove residual drug traces and grown on nutrient agar plates for 7 days. During this time, the bacteria reproduced, forming colonies, which were then counted at the end of the seventh day. Plates with more colonies were assumed to have more live bacteria at the end of the 1-hour incubation period. Table 1 shows the number of colonies counted. The drug-free control showed 50 colonies at the end of 7 days.Experiment 2Bacteria were handled as described in Experiment 1 with two exceptions: all drugs were tested at the same concentration and the incubation time of each culture was varied. Table 2 shows the number of colonies counted for Experiment 2.Experiment 3Permeability coefﬁcients measure a drug’s ability to break through the cell membrane of a bacterium. The larger the permeability coefﬁcient, the faster the drug is able to transfer through the membrane. The molecular mass, in atomic mass units (amu), and permeability coefﬁcient, in centimeters per second (cm/s) of the 5 drugs at 37 C were measured. The results are shown in Table 3.Q.In Experiment 1, what was the relationship between drug concentration and the drug’s effectiveness in killing penicillin-resistant bacteria?

View answer

Top Courses for ACTView all

ACT Mock Test Series 2025

Biology for ACT

How to Prepare for ACT

Mathematics for ACT

Chemistry for ACT

Top Courses for ACT

View all

Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.Based on the data in Figures 1 and 2, the researchers should make which of the following conclusions about the overall change in mean blood plasma concentration and mean symptom score over time following dosage?a)Both mean blood plasma concentration and mean symptom score increase then decrease.b)Both mean blood plasma concentration and mean symptom score decrease then increase.c)Mean blood plasma concentration increases then decreases, and mean symptom score decreases then increases.d)Mean blood plasma concentration decreases then increases, and mean symptom score increases then decreases.Correct answer is option 'C'. Can you explain this answer?

Share with a Friend

Answer this doubt

Question Description
Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.Based on the data in Figures 1 and 2, the researchers should make which of the following conclusions about the overall change in mean blood plasma concentration and mean symptom score over time following dosage?a)Both mean blood plasma concentration and mean symptom score increase then decrease.b)Both mean blood plasma concentration and mean symptom score decrease then increase.c)Mean blood plasma concentration increases then decreases, and mean symptom score decreases then increases.d)Mean blood plasma concentration decreases then increases, and mean symptom score increases then decreases.Correct answer is option 'C'. Can you explain this answer? for ACT 2025 is part of ACT preparation. The Question and answers have been prepared according to the ACT exam syllabus. Information about Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.Based on the data in Figures 1 and 2, the researchers should make which of the following conclusions about the overall change in mean blood plasma concentration and mean symptom score over time following dosage?a)Both mean blood plasma concentration and mean symptom score increase then decrease.b)Both mean blood plasma concentration and mean symptom score decrease then increase.c)Mean blood plasma concentration increases then decreases, and mean symptom score decreases then increases.d)Mean blood plasma concentration decreases then increases, and mean symptom score increases then decreases.Correct answer is option 'C'. Can you explain this answer? covers all topics & solutions for ACT 2025 Exam. Find important definitions, questions, meanings, examples, exercises and tests below for Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.Based on the data in Figures 1 and 2, the researchers should make which of the following conclusions about the overall change in mean blood plasma concentration and mean symptom score over time following dosage?a)Both mean blood plasma concentration and mean symptom score increase then decrease.b)Both mean blood plasma concentration and mean symptom score decrease then increase.c)Mean blood plasma concentration increases then decreases, and mean symptom score decreases then increases.d)Mean blood plasma concentration decreases then increases, and mean symptom score increases then decreases.Correct answer is option 'C'. Can you explain this answer?.

Solutions for Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.Based on the data in Figures 1 and 2, the researchers should make which of the following conclusions about the overall change in mean blood plasma concentration and mean symptom score over time following dosage?a)Both mean blood plasma concentration and mean symptom score increase then decrease.b)Both mean blood plasma concentration and mean symptom score decrease then increase.c)Mean blood plasma concentration increases then decreases, and mean symptom score decreases then increases.d)Mean blood plasma concentration decreases then increases, and mean symptom score increases then decreases.Correct answer is option 'C'. Can you explain this answer? in English & in Hindi are available as part of our courses for ACT. Download more important topics, notes, lectures and mock test series for ACT Exam by signing up for free.

Here you can find the meaning of Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.Based on the data in Figures 1 and 2, the researchers should make which of the following conclusions about the overall change in mean blood plasma concentration and mean symptom score over time following dosage?a)Both mean blood plasma concentration and mean symptom score increase then decrease.b)Both mean blood plasma concentration and mean symptom score decrease then increase.c)Mean blood plasma concentration increases then decreases, and mean symptom score decreases then increases.d)Mean blood plasma concentration decreases then increases, and mean symptom score increases then decreases.Correct answer is option 'C'. Can you explain this answer? defined & explained in the simplest way possible. Besides giving the explanation of Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.Based on the data in Figures 1 and 2, the researchers should make which of the following conclusions about the overall change in mean blood plasma concentration and mean symptom score over time following dosage?a)Both mean blood plasma concentration and mean symptom score increase then decrease.b)Both mean blood plasma concentration and mean symptom score decrease then increase.c)Mean blood plasma concentration increases then decreases, and mean symptom score decreases then increases.d)Mean blood plasma concentration decreases then increases, and mean symptom score increases then decreases.Correct answer is option 'C'. Can you explain this answer?, a detailed solution for Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.Based on the data in Figures 1 and 2, the researchers should make which of the following conclusions about the overall change in mean blood plasma concentration and mean symptom score over time following dosage?a)Both mean blood plasma concentration and mean symptom score increase then decrease.b)Both mean blood plasma concentration and mean symptom score decrease then increase.c)Mean blood plasma concentration increases then decreases, and mean symptom score decreases then increases.d)Mean blood plasma concentration decreases then increases, and mean symptom score increases then decreases.Correct answer is option 'C'. Can you explain this answer? has been provided alongside types of Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.Based on the data in Figures 1 and 2, the researchers should make which of the following conclusions about the overall change in mean blood plasma concentration and mean symptom score over time following dosage?a)Both mean blood plasma concentration and mean symptom score increase then decrease.b)Both mean blood plasma concentration and mean symptom score decrease then increase.c)Mean blood plasma concentration increases then decreases, and mean symptom score decreases then increases.d)Mean blood plasma concentration decreases then increases, and mean symptom score increases then decreases.Correct answer is option 'C'. Can you explain this answer? theory, EduRev gives you an ample number of questions to practice Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.Based on the data in Figures 1 and 2, the researchers should make which of the following conclusions about the overall change in mean blood plasma concentration and mean symptom score over time following dosage?a)Both mean blood plasma concentration and mean symptom score increase then decrease.b)Both mean blood plasma concentration and mean symptom score decrease then increase.c)Mean blood plasma concentration increases then decreases, and mean symptom score decreases then increases.d)Mean blood plasma concentration decreases then increases, and mean symptom score increases then decreases.Correct answer is option 'C'. Can you explain this answer? tests, examples and also practice ACT tests.

Explore Courses for ACT exam